Neurofilament Light Chain (NfL) and GFAP Plasma Levels Show No Significant Difference in Myasthenia Gravis vs. Controls
Plasma Biomarkers Show No Significant Link to Myasthenia Gravis Severity in New Study Plasma concentrations of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) do not differ between patients with myasthenia gravis (MG) and healthy controls, according to a study published via PubMed. The research found that neither biomarker correlated with the Myasthenia … Read more